LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms

Neuron

Volumn 43, Issue 3, 2004, Pages 333-344

  Deane, Rashid ^a   Wu, Zhenhua ^a   Sagare, Abhay ^a   Davis, Judianne ^b   Du Yan, Shi ^c   Hamm, Katie ^a   Xu, Feng ^b   Parisi, Margaret ^a   LaRue, Barbra ^a   Hu, Hong Wei ^c   Spijkers, Patricia ^d   Guo, Huang ^a   Song, Xiaomei ^a   Lenting, Peter J ^d   Van Nostrand, William E ^b   Zlokovic, Berislav V ^a  

^a Arthur K   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c The New York Presbyterian Hospital   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ISOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA SHEET; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN CELL; CAPILLARY; CELL CULTURE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; HAMSTER; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; TRANSCYTOSIS; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; CRICETINAE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN ISOFORMS;

EID: 4043061467     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2004.07.017     Document Type: Article

References (59)

1. Bu G. The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family. Int. Rev. Cytol. 209:2001;79-116
2. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henscehn A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554
3. Cheng T., Liu D., Griffin J.H., Fernandez J.A., Castellino F., Rosen E.D., Fukudome K., Zlokovic B.V. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat. Med. 9:2003;338-342
4. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., et al. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life. J. Neurosci. 23:2003;8844-8853
5. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:2002;32046-32053
6. Davis J., Xu F., Deane R., Romanov G., Prevetti M.L., Zeigler K., Zlokovic B.V., Van Nostrand W. Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor. J. Biol. Chem. 279:2004;20296-20306
7. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., et al. RAGE mediates amyloid-β transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9:2003;907-913
8. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-Aβ efflux. a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science. 295:2002;2264-2267. a
9. DeMattos R.B., O'Dell M.A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., Paul S.M., Aronow B.J., Holtzman D.M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 99:2002;10843-10849. b
10. Flood D.G., Reaume A.G., Dorfman K.S., Lin Y.-G., Lang D.M., Trusko S.P., Savage M.J., Annaert W.G., De Strooper B., Siman R., Scott R.W. FAD mutant PS-1 gene-targeted mice. increased Aβ42 and Aβ deposition without APP overproduction Neurobiol. Aging. 23:2002;335-348
11. Ghiso J., Frangione B. Amyloidosis and Alzheimer's disease. Adv. Drug Deliv. Rev. 54:2002;1539-1551
12. Golabek A.A., Soto C., Vogel T., Wisniewski T. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J. Biol. Chem. 271:1996;10602-10606
13. Grabowski T.J., Cho H.S., Vonsattel J.P.G., Rebeck G.W., Greenberg S.M. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49:2001;697-705
14. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A. Alzheimer's disease-affected brain. presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl. Acad. Sci. USA. 100:2003;10417-10422
15. Green P., Bu G. Genetics and molecular biology. phosphorylation of low-density lipoprotein receptor-related proein by platelet-derived growth factor Curr. Opin. Lipidol. 13:2002;569-572
16. Guenétte S.Y., Ghang Y., Hyman B.T., Tanzi R.E., Rebeck G.W. Low-density lipoprotein receptor-related protein levels and endocytic function are reduced by overexpression of the FE65 adaptor protein, FE65L1. J. Neurochem. 82:2002;755-762
17. Guo H., Liu D., Gelbard H., Cheng T., Fernandez J.A., Insalaca R., Griffin J.H., Zlokovic B.V. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 41:2004;563-572
18. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease. progress and problems on the road to therapeutics Science. 297:2002;353-356
19. Herz J. The LDL receptor gene family. (un)expected signal transducers in the brain Neuron. 29:2001;571-581
20. Herz J., Strickland D.K. Lrp. a multifunctional scavenger and signaling receptor J. Clin. Invest. 108:2001;779-784
21. Herz J., Marschang P. Coaxing the LDL receptor family into the blood. Cell. 112:2003;289-292
22. Herz J., Kowal R.C., Goldstein J.L., Brown M.S. Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 9:1990;1769-1776
23. Hollenbach E., Ackermann S., Hyman B.T., Rebeck G.W. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology. 50:1998;1905-1907
24. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102
25. Jordán J., Galindo M.F., Miller R.J., Reardon C.A., Getz G.S. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18:1998;195-204
26. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:1997;56-61
27. Kang D.E., Pietrzik C.U., Baum L., Chevallier N., Merriam D.E., Kounnas M.Z., Wagner S.L., Troncoso J.C., Kawas C.H., Katzman R., Koo E.H. Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest. 106:2000;1159-1166
28. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid Aβ protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;372-381
29. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:2003;486-489
30. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., Hymann B.T., Strickland D.K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell. 82:1995;331-340
31. Lambert J.C., Wavrant-De Vrieze F., Amouyel P., Chartier-Harlin M.C. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet. 351:1998;1787-1788
32. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberberg I., van Duinen S.G., Bots G.T., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248:1990;1124-1126
33. Li Y., Lu W., Marzolo M.P., Bu G. Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endoytosis rates. J. Biol. Chem. 276:2001;18000-18006
34. Mackic J.B., Stins M., McComb J.G., Calero M., Ghiso J., Kim K.S., Yan S.D., Stern D., Schmidt A.M., Frangione B., Zlokovic B.V. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40. asymmetrical binding, endocytosis and transcytosis at the apical side of brain microvascular endothelial cell monolayer J. Clin. Invest. 102:1998;734-743
35. Matsuoka Y., Saito M., LaFrancois J., Saito M., Taylor K., Olm V., Wang L., Casey E., Lu Y., Shiratori C., et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to Aβ-amyloid. J. Neurosci. 23:2003;29-33
36. Melman L., Geuze H.J., Li Y., McCormick L.M., van Kerkhof P., Strous G.J., Schwartz A.L., Bu G. Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway. Mol. Biol. Cell. 13:2002;3325-3335
37. 2- macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911
38. Pietrzik C.U., Busse T., Merriam D.E., Weggen S., Koo E.H. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J. 21:2002;5691-5700
39. 2- macroglobulin enhances the clearance of endogenous soluble β-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J. Neurochem. 73:1999;1393-1398
40. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8:2002;403-409
41. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron. 32:2001;177-180
42. 1-40 peptide from brain by low-density lipoprotein receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106:2000;1489-1499
43. 125I to high specific activity. Biochim. Biophys. Acta. 251:1971;363-366
44. Ulery P.G., Beers J., Mikhailenko I., Tanzi R.E., Rebeck G.W., Hyman B.T., Strickland D.K. Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J. Biol. Chem. 275:2000;7410-7415
45. van der Geer P. Phosphorylation of LRP1. regulation of transport and signal transduction Trends Cardiovasc. Med. 12:2002;160-165
46. Van Nostrand W.E., Melchor J.P., Cho H.S., Greenberg S.M., Rebeck G.W. Pathogenic effects of D23N "Iowa" amyloid β-protein. J. Biol. Chem. 276:2001;32860-32866
47. Van Uden E., Mallory M., Veinbergs I., Alford M., Rockenstein E., Masliah E. Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. J. Neurosci. 22:2002;9298-9304
48. Veinbergs I., Van Uden E., Mallory M., Alford M., McGiffert C., DeTeresa R., Orlando R., Masliah E. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp. Neurol. 170:2001;15-26
49. Vinters H.V., Farag E.S. Amyloidosis of cerebral arteries. Adv. Neurol. 92:2003;105-112
50. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539
51. Wang X., Lee S., Arai K., Lee S., Tsuji K., Rebeck G.W., Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat. Med. 9:2003;1313-1317
52. Wavrant-DeVrieze F., Lambert J.C., Stas L., Crook R., Cottel D., Pasquier F., Frigard B., Lambrechts M., Thiry E., Amouyel P., et al. Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum. Genet. 104:1999;432-434
53. Westein E., Denis C.V., Bouma B.N., Lenting P.J. The α-chains of C4b-binding protein mediate complex formation with low density liporpoprotein receptor-related protein. J. Biol. Chem. 277:2002;2511-2516
54. Willnow T.E., Rohlmann A., Horton J., Otani H., Braun J.R., Hammer R.E., Herz J. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15:1996;2632-2639
55. Wu Z., Hofman F.M., Zlokovic B.V. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J. Neurosci. Methods. 130:2003;53-63
56. Zerbinatti C.V., Wozniak D.F., Cirrito J., Cam J.A., Osaka H., Bales K.R., Zhuo M., Paul S.M., Holtzman D.H., Bu G. Increased soluble amyloid β peptide and memory deficits in amyloid model mice overexpressing the LDL receptor-related protein. Proc. Natl. Acad. Sci. USA. 101:2004;1075-1080
57. Zlokovic B.V., Frangione B. Transport-clearance hypothesis for Alzheimer's disease and potential therapeutic implications. Saido T. Aβ Metabolism in Alzheimer's Disease. 2003;114-122 Landes Bioscience, Georgetown, TX
58. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B., Ghiso J. Glycoprotein 330/megalin. probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid-Aβ at the blood-brain and blood-cerebrospinal fluid barriers Proc. Natl. Acad. Sci. USA. 93:1996;4229-4236
59. Zlokovic B.V., Yamada S., Holtzman D., Ghiso J., Frangione B. Clearance of amyloid-Aβ-peptide from brain. transport or metabolism? Nat. Med. 6:2000;718-719